Fluoroquinolones: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "* " to "*") |
Ostermayer (talk | contribs) |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 7: | Line 7: | ||
==Adverse Effects== | ==Adverse Effects== | ||
*Common adverse effects | |||
**GI and neuro toxicity | |||
**Rash | |||
**QT prolongation | |||
**Hyper/hypoglycemia | |||
**Hematologic toxicity | |||
**Depression/Suicidality | |||
*Black box warning from US FDA | *Black box warning from US FDA | ||
**Tendonitis and tendon rupture<ref>Gültuna S. et al. Ciprofloxacin induced tendinitis. J Clin Rheumatol. 2009;15 (4): 201-2</ref> | |||
**Peripheral Neuropathy<ref>Food and Drug Administration: Drug safety announcement about fluoroquinolones and possible peripheral neuropathy [http://www.fda.gov/downloads/Drugs/DrugSafety/UCM365078.pdf PDF]</ref> | |||
==List of Fluoroquinolones== | |||
{{#ask:[[Is DrugClass::Fluoroquinolone]] |format=ul }} | |||
{{Template:Clinically Utilized Antibiotics}} | {{Template:Clinically Utilized Antibiotics}} | ||
==See Also== | ==See Also== | ||
*[[Antibiotics (Main)]] | *[[Antibiotics (Main)]] | ||
==External Links== | |||
*[http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm126085.htm FDA info for Health Professionals] | |||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:ID]] | [[Category:ID]] | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
Latest revision as of 12:43, 30 August 2025
Indications
- UTI (2nd line)
- Prostatitis
- Chlamydia
- PID
- Traveler's Diarrhea
Adverse Effects
- Common adverse effects
- GI and neuro toxicity
- Rash
- QT prolongation
- Hyper/hypoglycemia
- Hematologic toxicity
- Depression/Suicidality
- Black box warning from US FDA
List of Fluoroquinolones
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||